Shyam Srinivasan

Two questions for me. First, on the new block that we had actually put for one of the molecules, which is largely for that Rs. 128 crore, has that been completely, I believe we did some early commercialization in Q1FY26, but in Q2FY26, we should assume that many of that, this new block is being used. Would that be fair?

Saharsh, we have gone from 50 metric ton, if I remember right, to 150. So, is there some measure of what the utilization is and is there a way for us to see how much can likely come through in the path forward?

Perfect. Okay. My second question is just on the cash flow. It's just on the cash flow statement. Abhijit, you mentioned about some of the challenges of uneven order flow at the start. But when I look at like last September to this September, I think even receivables, we have seen like a big change. So, is there anything we need to be worried about? Is the terms changed with some of the customers?